Search research articles
Contact Us
Filters
Showing results (31-40 of 35) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 35 results.
Journal of Neurology
|
September 1, 2023
Hypokalemic periodic paralysis: a 3-year follow-up study
Sonja Holm-Yildiz, Thomas Krag, Nanna Witting, et al.
Muscle & Nerve
|
December 24, 2024
Muscle Contractility in Hypokalemic Periodic Paralysis
Sonja Holm-Yildiz, Thomas Krag, Tina Dysgaard, et al.
Vaccines
|
September 27, 2025
Humoral Immune Response Following COVID-19 Vaccination in Multifocal Motor Neuropathy and Chronic Inflammatory Demyelinating Polyneuropathy
Louise Sloth Kodal, Sonja Holm-Yildiz, Sebastian Rask Hamm, et al.
Journal of Neuroimmunology
|
October 5, 2023
Humoral immune response to COVID-19 vaccine in patients with myasthenia gravis
Sonja Holm-Yildiz, Tina Dysgaard, Thomas Krag, et al.
The Lancet. Neurology
|
September 20, 2024
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial
Jeffrey A Allen, Jie Lin, Ivana Basta, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 35) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 35 results.
Journal of Neurology
|
September 1, 2023
Hypokalemic periodic paralysis: a 3-year follow-up study
Sonja Holm-Yildiz, Thomas Krag, Nanna Witting, et al.
Muscle & Nerve
|
December 24, 2024
Muscle Contractility in Hypokalemic Periodic Paralysis
Sonja Holm-Yildiz, Thomas Krag, Tina Dysgaard, et al.
Vaccines
|
September 27, 2025
Humoral Immune Response Following COVID-19 Vaccination in Multifocal Motor Neuropathy and Chronic Inflammatory Demyelinating Polyneuropathy
Louise Sloth Kodal, Sonja Holm-Yildiz, Sebastian Rask Hamm, et al.
Journal of Neuroimmunology
|
October 5, 2023
Humoral immune response to COVID-19 vaccine in patients with myasthenia gravis
Sonja Holm-Yildiz, Tina Dysgaard, Thomas Krag, et al.
The Lancet. Neurology
|
September 20, 2024
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial
Jeffrey A Allen, Jie Lin, Ivana Basta, et al.
Page
of 4